Plenty of people think that, when a vaccine does arrive, their country should get it first
, plenty of people think that, when a vaccine does arrive, their country should get it first. Between March and September, researchers from the United Nations and the International Security and Development Centre, a research group in Berlin, polled some 11,600 people from 137 countries about their experience with covid-19. One of the questions asked how a vaccine should be distributed.
Such selfish views were surprisingly common. In Brazil, Finland and Portugal, over 40% of respondents said they wanted special access. In America, a whopping 46% said they wanted first dibs on a vaccine; just 41% said it should be made available worldwide . Indeed, of the countries with at least 150 survey responses, the United States was the only one whose residents preferred the selfish answer to either of the other options.
No matter who develops an effective vaccine first, those clamouring for it may be disappointed. Although Donald Trump has brashly promised to manufacture enough doses for every American by April, the head of Britain’s vaccine task-force
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Covid-19 Vaccine Frontrunner Moderna Won’t Enforce Vaccine Patents During PandemicThis would allow other companies developing coronavirus vaccines to use Moderna’s technology.
Weiterlesen »
Q&A: Where are we in the COVID-19 vaccine race?Drugmakers and research centers around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway.
Weiterlesen »
FDA wants two months of safety data before considering Covid-19 vaccineThe US FDA made clear it will want to see two months of follow-up data after volunteers get their second dose of vaccine as part of clinical trials testing potential coronavirus vaccines.
Weiterlesen »
New FDA guidance on Covid-19 vaccine trials makes Election Day approval unlikelyGiven the timeline of when clinical trials began, new FDA guidance indicates the earliest a Covid-19 vaccine might get authorization would be the end of November.
Weiterlesen »
China's experimental COVID-19 vaccine appears safe - studyA Chinese experimental coronavirus vaccine being developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences was shown to be safe in an early stage clinical trial, researchers said.
Weiterlesen »
Could The Live Flu Vaccine Help You Fight Off COVID-19?There's evidence that certain vaccines boost the body's defense against many kinds of illness. Scientists are investigating whether this benefit extends to protection from COVID-19.
Weiterlesen »